Ryvu Therapeutics S.A.

WSE:RVU 주식 보고서

시가총액: zł1.2b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Ryvu Therapeutics 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Pawel Przewiezlikowski

최고 경영자

zł1.1m

총 보상

CEO 급여 비율78.4%
CEO 임기no data
CEO 소유권17.4%
경영진 평균 재임 기간3yrs
이사회 평균 재임 기간5yrs

최근 관리 업데이트

Recent updates

Despite Lacking Profits Ryvu Therapeutics (WSE:RVU) Seems To Be On Top Of Its Debt

Oct 20
Despite Lacking Profits Ryvu Therapeutics (WSE:RVU) Seems To Be On Top Of Its Debt

We're Keeping An Eye On Ryvu Therapeutics' (WSE:RVU) Cash Burn Rate

Aug 02
We're Keeping An Eye On Ryvu Therapeutics' (WSE:RVU) Cash Burn Rate

Are Investors Undervaluing Ryvu Therapeutics S.A. (WSE:RVU) By 20%?

Jan 25
Are Investors Undervaluing Ryvu Therapeutics S.A. (WSE:RVU) By 20%?

What Type Of Shareholders Own The Most Number of Ryvu Therapeutics S.A. (WSE:RVU) Shares?

Feb 05
What Type Of Shareholders Own The Most Number of Ryvu Therapeutics S.A. (WSE:RVU) Shares?

Shareholders Of Ryvu Therapeutics (WSE:RVU) Must Be Happy With Their 261% Total Return

Dec 14
Shareholders Of Ryvu Therapeutics (WSE:RVU) Must Be Happy With Their 261% Total Return

CEO 보상 분석

Pawel Przewiezlikowski 의 보수는 Ryvu Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-zł96m

Mar 31 2024n/an/a

-zł94m

Dec 31 2023zł1mzł838k

-zł92m

Sep 30 2023n/an/a

-zł73m

Jun 30 2023n/an/a

-zł66m

Mar 31 2023n/an/a

-zł75m

Dec 31 2022zł341kzł165k

-zł84m

Sep 30 2022n/an/a

-zł94m

Jun 30 2022n/an/a

-zł105m

Mar 31 2022n/an/a

-zł92m

Dec 31 2021zł1mn/a

-zł79m

Sep 30 2021n/an/a

-zł72m

Jun 30 2021n/an/a

-zł61m

Mar 31 2021n/an/a

-zł41m

Dec 31 2020n/an/a

-zł32m

Sep 30 2020n/an/a

-zł40m

Jun 30 2020n/an/a

-zł32m

Mar 31 2020n/an/a

-zł41m

Dec 31 2019zł524kzł524k

-zł44m

Sep 30 2019n/an/a

-zł53m

Jun 30 2019n/an/a

-zł60m

Mar 31 2019n/an/a

-zł28m

Dec 31 2018zł476kzł476k

-zł23m

Sep 30 2018n/an/a

zł2m

Jun 30 2018n/an/a

zł14m

Mar 31 2018n/an/a

zł21m

Dec 31 2017zł655kzł655k

zł6m

보상 대 시장: Pawel 의 총 보상 ($USD 278.84K )은 Polish 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 392.70K ).

보상과 수익: 회사가 수익성이 없는 동안 Pawel 의 보상이 증가했습니다.

CEO

Pawel Przewiezlikowski

no data

테뉴어

zł1,068,120

보상

Mr. Pawel Tadeusz Przewiezlikowski, MSc., MBA, serves as the Chief Executive Officer of BioCentrum Sp. z o.o. Mr. Przewiezlikowski serves as a Member of Supervisory Board of SELVITA S.A.Mr. Przewiezlikow...

리더십 팀

이름위치테뉴어보상소유권
Pawel Przewiezlikowski
Founderno datazł1.07m17.44%
PLN 210.5m
Krzysztof Brzózka
Executive VP12.7yrszł1.43m1.16%
PLN 14.0m
Kamil Sitarz
COO & Member of the Management Board3.8yrszł1.18m0.17%
PLN 2.0m
Vatnak Vat-Ho
Chief Business Officer & Member of Management Board2.1yrszł2.22m0.18%
PLN 2.2m
Hendrik Nogai
Chief Medical Officer & Member of Management Board2.1yrszł2.17m0.058%
PLN 704.7k
Paulina Wolanin
Human Resources Managerno data데이터 없음데이터 없음

3.0yrs

평균 재임 기간

경험이 풍부한 관리: RVU 의 관리팀은 경험 ( 2.7 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Peter Smith
Member of Supervisory Board1.3yrszł90.15k데이터 없음
Rafal Chwast
Independent Member of the Supervisory Boardno datazł159.99k0.52%
PLN 6.3m
Tadeusz Wesolowski
Non-Independent Vice Chairman of Supervisory Boardno datazł157.23k0.40%
PLN 4.9m
Scott Fields
Member of Supervisory Board1.3yrszł121.27k데이터 없음
Piotr Romanowski
Independent Chairman of the Supervisory Board13.7yrszł159.78k0.22%
PLN 2.6m
Axel Glasmacher
Non-Independent Member of the Supervisory Board5yrszł157.23k데이터 없음
Thomas Turalski
Non-Independent Member of the Supervisory Board5yrszł157.23k0.087%
PLN 1.0m

5.0yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: RVU 의 이사회는 경험(평균 재직 기간 4.8 년)으로 간주됩니다.